Li, S <br/><br/>
A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts.  [electronic resource] 

 -  The Annals of thoracic surgery  Oct 2001 
 - 1306-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4975 
<br/><br/><label>Standard No.: </label>10.1016/s0003-4975(01)03066-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Animals<br/>Antigens, CD<br/>Antigens, Differentiation--pharmacology<br/>Antilymphocyte Serum--pharmacology<br/>Bone Marrow Transplantation--immunology<br/>CTLA-4 Antigen<br/>Graft Survival--immunology<br/>Heart Transplantation--immunology<br/>Humans<br/>Immunoconjugates<br/>Rats<br/>Rats, Inbred ACI<br/>Rats, Inbred WF<br/>Skin Transplantation--immunology<br/>Transplantation Chimera--immunology<br/>Transplantation Tolerance--immunology